» Articles » PMID: 37249897

NR4A1 Aggravates Myocardial Ischaemia-Reperfusion Injury by Inhibiting OPA1-Mediated Mitochondrial Fusion

Overview
Publisher Springer
Date 2023 May 30
PMID 37249897
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial fusion is an important process that protects the myocardium. However, mitochondrial fusion is often inhibited in myocardial ischaemia-reperfusion injury (IR). The upstream mechanism of this effect is unclear. Nuclear receptor subfamily 4 group A member 1 (NR4A1) can aggravate myocardial IR and increase the level of oxidative stress, thereby affecting mitochondrial function and morphology. Inhibiting NR4A1 can improve oxidative stress levels and mitochondrial function and morphology, thereby reducing IR. Downregulating NR4A1 increases the expression level of the mitochondrial fusion-related protein optic atrophy 1 (OPA1), which is associated with these benefits. Inhibiting OPA1 expression with MYLS22 abrogates the effects of NR4A1 downregulation on IR. Furthermore, NR4A1 disrupts mitochondrial dynamics and activates the STING and NF-κB pathways. Insufficient mitochondrial fusion and increased apoptosis and inflammatory reactions worsen irreversible damage to cardiomyocytes. In conclusion, NR4A1 can exacerbate IR by inhibiting OPA1, causing mitochondrial damage.

Citing Articles

Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy.

Wang J, Zhuang H, Jia L, He X, Zheng S, Ji K Int J Biol Sci. 2024; 20(11):4458-4475.

PMID: 39247823 PMC: 11380451. DOI: 10.7150/ijbs.95853.


[PDCD4 knockdown ameliorates lipopolysaccharide-induced endothelial cell damage by improving mitochondrial dynamics].

Yu J, Li R, Xia T, Wang J, Jin J, Yuan M Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(1):25-35.

PMID: 38293973 PMC: 10878903. DOI: 10.12122/j.issn.1673-4254.2024.01.04.

References
1.
Hausenloy D, Yellon D . Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016; 13(4):193-209. DOI: 10.1038/nrcardio.2016.5. View

2.
Konijnenberg L, Damman P, Duncker D, Kloner R, Nijveldt R, van Geuns R . Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res. 2019; 116(4):787-805. PMC: 7061278. DOI: 10.1093/cvr/cvz301. View

3.
Wang J, Zhou H . Mitochondrial quality control mechanisms as molecular targets in cardiac ischemiareperfusion injury. Acta Pharm Sin B. 2020; 10(10):1866-1879. PMC: 7606115. DOI: 10.1016/j.apsb.2020.03.004. View

4.
Chang X, Lochner A, Wang H, Wang S, Zhu H, Ren J . Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control. Theranostics. 2021; 11(14):6766-6785. PMC: 8171103. DOI: 10.7150/thno.60143. View

5.
Chan D . Mitochondrial Dynamics and Its Involvement in Disease. Annu Rev Pathol. 2019; 15:235-259. DOI: 10.1146/annurev-pathmechdis-012419-032711. View